Intensive Breast Screening in BRCA2 Mutation Carriers Is Associated With Reduced Breast Cancer Specific and All Cause Mortality

Hereditary Cancer in Clinical Practice - United Kingdom
doi 10.1186/s13053-016-0048-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer

Cancers
Cancer ResearchOncology
2018English

Plasma Osteoprotegerin and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Oncotarget
Oncology
2016English

A Prior Diagnosis of Breast Cancer Is a Risk Factor for Breast Cancer in BRCA1 and BRCA2 Carriers

Current Oncology
Oncology
2014English

RASSF1A Polymorphism A133S Is Associated With Early Onset Breast Cancer in BRCA1/2 Mutation Carriers

Cancer Research
Cancer ResearchOncology
2008English

Breast Cancer Screening and Mortality

Nature Reviews Clinical Oncology
Oncology
2010English

Methionine-Dependence Phenotype in the De Novo Pathway in BRCA1 and BRCA2 Mutation Carriers With and Without Breast Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2008English

Dietary Isoflavone Intake and All-Cause Mortality in Breast Cancer Survivors: The Breast Cancer Family Registry-Methodological Issues

Cancer
Cancer ResearchOncology
2017English

Phenotypic Analysis of Familial Breast Cancer: Comparison of BRCAx Tumors With BRCA1-, BRCA2-carriers and Non-Familial Breast Cancer

European Journal of Surgical Oncology
MedicineOncologySurgery
2015English

Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

JAMA - Journal of the American Medical Association
Medicine
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy